为什么目前的治疗不能治愈喘. 是时候转向一个健康方法了吗?
1Department of Medical Sciences, University of Torino, Torino, Italy.
Journal of asthma and allergy
|September 11, 2023
概括
喘是一种慢性呼吸道疾病,在一些人中可能会自发消失. 了解这些愈合机制是开发超越当前症状管理的新治疗方法的关键.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 环境健康 环境健康
背景情况:
- 喘仍然无法治愈,尽管有治疗方法可以控制症状.
- 自发性喘缓解很少发生,为潜在的愈合机制提供了洞察力.
- 目前的治疗方法侧重于下游的炎症媒介,而不是根本原因.
研究的目的:
- 探索自发性喘治愈背后的机制.
- 研究影响喘进展和缓解的环境因素.
- 为了确定新的治疗策略,以完全缓解喘.
主要方法:
- 对自发性喘治愈病例的分析.
- 评估环境干预措施,例如从弱势社区搬迁.
- 评估阿尔卑斯山高地气候处理的有效性.
- 考虑喘研究的一种健康方法.
主要成果:
- 环境干预措施,如搬迁,显示喘恶化显著减少,与标准治疗相比或超过标准治疗.
- 阿尔卑斯山的气候治疗改善了喘控制,生活质量,并减少了恶化/住院治疗.
- 了解自发愈合机制对于开发治愈策略至关重要.
结论:
- 将注意力从症状管理转移到理解自发愈合和环境影响是喘治愈所必需的.
- 一个健康的方法为综合性喘预防和治疗研究提供了一个有前途的框架.
- 需要针对天生的免疫和环境相互作用的新策略来实现完全的喘缓解.
相关概念视频
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332


